Related Experiment Videos
Altered pre-lamin A processing is a common mechanism leading to lipodystrophy
Cristina Capanni1, Elisabetta Mattioli, Marta Columbaro
1ITOI, CNR, Unit of Bologna, c/o IOR, Bologna, Italy.
Human Molecular Genetics
|April 22, 2005
Summary
Inherited lipodystrophies involve abnormal fat distribution. This study reveals that accumulated pre-lamin A sequesters SREBP1, impairing adipocyte differentiation, a defect potentially treatable with PPARgamma activators.
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- Lipodystrophies are rare genetic disorders characterized by abnormal fat distribution, insulin resistance, and metabolic dysfunction.
- The molecular mechanisms underlying inherited lipodystrophies are not fully understood but are linked to mutations in genes like lamin A/C and PPARgamma.
- Laminopathies, diseases caused by lamin A/C gene mutations, can manifest with lipodystrophic phenotypes.
Purpose of the Study:
- To investigate the role of lamin A/C processing in lipodystrophic phenotypes.
- To elucidate the molecular interactions between pre-lamin A and adipocyte differentiation factors.
- To explore potential therapeutic strategies for lipodystrophy-associated impaired adipogenesis.
Main Methods:
- Analysis of lamin A/C processing in fibroblasts from patients with Dunnigan type familial partial lipodystrophy, mandibuloacral dysplasia, and atypical Werner's syndrome.
- Co-immunoprecipitation assays to detect in vivo interactions between pre-lamin A and sterol regulatory element binding protein 1 (SREBP1).
- Inhibition of lamin A precursor processing in 3T3-L1 pre-adipocytes to study effects on adipogenesis and rescue experiments using troglitazone.
Main Results:
- Accumulation of the precursor protein, pre-lamin A, was observed specifically in cells from lipodystrophy patients.
- Pre-lamin A was found to interact in vivo with SREBP1 at the nuclear envelope, sequestering it and reducing active SREBP1 levels.
- Impaired pre-adipocyte differentiation due to pre-lamin A accumulation could be rescued by treatment with troglitazone, a PPARgamma ligand.
Conclusions:
- Pre-lamin A accumulation disrupts adipocyte differentiation by sequestering SREBP1, thereby inhibiting PPARgamma activation.
- This finding provides a molecular link between lamin A/C defects and the pathogenesis of lipodystrophy.
- Targeting PPARgamma activation may offer a therapeutic avenue for certain lipodystrophies.